A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Clinical trial NCT06806592 · RECRUITING

Trial details

NCT number: NCT06806592
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Interstitial Lung Diseases Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases

Start date: 2025-09-13
Primary completion: 2027-07-17
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.